NCT02172235View on ClinicalTrials.gov

Relative Bioavailability of Pioglitazone After Co-administration With Different Doses of BI 10773 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

July 31, 2010

Conditions
Healthy
Interventions
DRUG

Pioglitazone

DRUG

Pioglitazone - low dose

DRUG

BI 10773 - low dose

DRUG

BI 10773 - medium dose

DRUG

BI 10773 - high dose

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02172235 - Relative Bioavailability of Pioglitazone After Co-administration With Different Doses of BI 10773 in Healthy Volunteers | Biotech Hunter | Biotech Hunter